What is the ROCE (Return on Capital Employed) of Camurus this year?
The ROCE of Camurus is 0.36 undefined this year.
Camurus ROCE 2024
Camurus ROCE
0.36
Ticker
CAMX.ST
ISIN
SE0007692850
WKN
A2ABG7
In 2024, Camurus's return on capital employed (ROCE) was 0.36, a 446.76% increase from the 0.07 ROCE in the previous year.
Camurus Aktienanalyse
What does Camurus do?
Camurus AB is a Swedish biopharmaceutical company that specializes in the development of innovative medications for the treatment of serious diseases. The company was founded in 1991 by an interdisciplinary team of chemists, biologists, and drug developers and is headquartered in Lund, Sweden. Camurus AB specializes in the development of medications based on long-acting drug release technology. This technology allows medications to be administered in a very precise manner and over a longer period of time. This enables the benefits of a constant drug concentration in the blood to be utilized without requiring multiple doses per day. The core business of Camurus AB includes the development of medications for the treatment of pain, cancer, and addiction. The company works closely with clients, partners, and academic institutions to bring innovative medications to market that can have a significant impact on patients' lives. One of Camurus AB's key areas is pain therapy. The company has developed a novel technology that allows pain medications to be administered in the form of sprays and patches. This technology is based on the release of buprenorphine, a potent painkiller that previously could only be administered as repeated single doses or in the form of an implant due to its short half-life. The extended release allows for a sustained high concentration of the drug in the blood, without the need for the patient to take multiple single doses. Camurus AB is also active in oncology and has developed medications for the treatment of breast and prostate cancer that also utilize long-acting drug release. These medications help patients better tolerate the side effects of chemotherapy and improve their quality of life. Another important area for Camurus AB is addiction therapy. The company has developed a medication based on buprenorphine for the treatment of opioid dependence. This medication activates the body's own opioid receptors and reduces the cravings for further drugs. In recent years, Camurus AB has introduced several important products to the market and holds a wide portfolio of patents and protective rights. The company is committed to improving patient care and making global healthcare a better and more effective system. In conclusion, Camurus AB is an innovative biopharmaceutical company specializing in the development of medications for the treatment of pain, cancer, and addiction. The company is dedicated to improving global healthcare and works closely with clients, partners, and academic institutions to develop innovative, effective, and patient-oriented solutions. Camurus ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Camurus's Return on Capital Employed (ROCE)
Camurus's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Camurus's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Camurus's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Camurus’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Camurus stock
How has the ROCE (Return on Capital Employed) of Camurus developed compared to the previous year?
The ROCE of Camurus has increased by 446.76% increased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Camurus?
A high Return on Capital Employed (ROCE) indicates that Camurus has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Camurus?
A low ROCE (Return on Capital Employed) can indicate that Camurus has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Camurus impact the company?
An increase in the ROCE of Camurus can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Camurus affect the company?
A decrease in ROCE of Camurus can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Camurus?
Some factors that can affect Camurus's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Camurus so important for investors?
The ROCE of Camurus is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Camurus take to improve the ROCE?
To improve the ROCE, Camurus can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Camurus pay?
Over the past 12 months, Camurus paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Camurus is expected to pay a dividend of 0 SEK.
What is the dividend yield of Camurus?
The current dividend yield of Camurus is .
When does Camurus pay dividends?
Camurus pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Camurus?
Camurus paid dividends every year for the past 0 years.
What is the dividend of Camurus?
For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.
In which sector is Camurus located?
Camurus is assigned to the 'Health' sector.
Wann musste ich die Aktien von Camurus kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Camurus from 10/4/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.
When did Camurus pay the last dividend?
The last dividend was paid out on 10/4/2024.
What was the dividend of Camurus in the year 2023?
In the year 2023, Camurus distributed 0 SEK as dividends.
In which currency does Camurus pay out the dividend?
The dividends of Camurus are distributed in SEK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Camurus
Our stock analysis for Camurus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Camurus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
